Nigeria is beginning to record early gains from a federal emergency care programme aimed at reducing maternal and newborn ...
Cystinosis requires lifelong cystine-depleting therapy; however, currently approved cysteamine products, Cystagon® and Procysbi®, are associated with frequent dosing, gastrointestinal intolerance, and ...
SPRINGDALE, Ark., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, ...
Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results